AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 132 min read

AJB Investment Fund II, LP (Bradley Adam James, Bradley Melinda Hodges) purchased $36K of JCTC (indirect holdings)

AJB Investment Fund II, LP purchased 12,259 indirectly-held shares of JEWETT CAMERON TRADING CO LTD (JCTC) at an average of $2.91 ($2.90–$2.93) across 7 trades over 2026-10-08 to 2026-10-12. Filed jointly with AJB Capital, LLC (10% owner), Bradley Adam James (10% owner) and Bradley Melinda Hodges (10% owner).

Original reporting
SEC EDGAR · AJB Investment Fund II, LP, AJB Capital, LLC, Bradley Adam James, Bradley Melinda Hodges
Published Oct 13, 2026, 10:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 10:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$JCTC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The disclosure provides transaction size, price range, and post-transaction holdings, but it does not include any company-specific news catalyst that would typically drive trading decisions.

02

Market read

This is primarily sentiment/positioning information from an insider-related entity, with limited incremental value for price discovery absent additional company catalysts.

03

What to watch

The article does not state whether the fund’s stake change is part of a broader accumulation program, nor does it provide any linkage to company catalysts (earnings, guidance, contracts, or litigation).

Relevance 4/10Novelty 2/10Timing: filed 2026-10-13, covering purchases from 2026-10-08 to 2026-10-12

Background

The article is an SEC Form 4 insider transaction disclosure, reporting open-market purchases by AJB Investment Fund II, LP (10% owner) in JEWETT CAMERON TRADING CO LTD (JCTC).

Market effects

Sector

No sector read-through; this is a small insider fund purchase with no disclosed operational or strategic change.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the filing is an indirect holding by a 10% owner fund, it may reflect portfolio rebalancing rather than a strong near-term view on the issuer’s fundamentals.

Key entities

  • insider_reporting_entity
    AJB Investment Fund II, LP

    10% owner reporting open-market purchases via SEC Form 4.

  • issuer
    JEWETT CAMERON TRADING CO LTD

    The Form 4 issuer referenced as JCTC, with indirect holdings reported by the fund.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

JCTC insider trading history →

Related articles

OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min